3.24.1.1.u2 html 60 143 1 false 24 0 false 3 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.merrimackpharma.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 100010 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.merrimackpharma.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 100020 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://www.merrimackpharma.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 100040 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss Sheet http://www.merrimackpharma.com/20240331/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss Condensed Consolidated Statements of Operations and Comprehensive Loss Statements 4 false false R5.htm 100050 - Statement - Condensed Consolidated Statements of Stockholders' Equity Sheet http://www.merrimackpharma.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquity Condensed Consolidated Statements of Stockholders' Equity Statements 5 false false R6.htm 100060 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://www.merrimackpharma.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlows Condensed Consolidated Statements of Cash Flows Statements 6 false false R7.htm 100070 - Disclosure - Nature of the Business Sheet http://www.merrimackpharma.com/20240331/taxonomy/role/Role_DisclosureNatureOfBusiness Nature of the Business Notes 7 false false R8.htm 100080 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.merrimackpharma.com/20240331/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 100090 - Disclosure - Discontinued Operations - Sale of Commercial Business Sheet http://www.merrimackpharma.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsSaleOfCommercialBusiness Discontinued Operations - Sale of Commercial Business Notes 9 false false R10.htm 100100 - Disclosure - Fair Value of Financial Instruments Sheet http://www.merrimackpharma.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstruments Fair Value of Financial Instruments Notes 10 false false R11.htm 100110 - Disclosure - Accounts Payable, Accrued Expenses and Other Sheet http://www.merrimackpharma.com/20240331/taxonomy/role/Role_DisclosureAccountsPayableAccruedExpensesAndOther Accounts Payable, Accrued Expenses and Other Notes 11 false false R12.htm 100120 - Disclosure - Stock-Based Compensation Sheet http://www.merrimackpharma.com/20240331/taxonomy/role/Role_DisclosureStockBasedCompensation Stock-Based Compensation Notes 12 false false R13.htm 100130 - Disclosure - Net Income (Loss) Per Common Share Sheet http://www.merrimackpharma.com/20240331/taxonomy/role/DisclosureNetIncomeLossPerCommonShare Net Income (Loss) Per Common Share Notes 13 false false R14.htm 100140 - Disclosure - Recent Accounting Pronouncements Sheet http://www.merrimackpharma.com/20240331/taxonomy/role/Role_DisclosureRecentAccountingPronouncements Recent Accounting Pronouncements Notes 14 false false R15.htm 100150 - Disclosure - Subsequent Events Sheet http://www.merrimackpharma.com/20240331/taxonomy/role/DisclosureSubsequentEvents Subsequent Events Notes 15 false false R16.htm 100160 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.merrimackpharma.com/20240331/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.merrimackpharma.com/20240331/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies 16 false false R17.htm 100170 - Disclosure - Discontinued Operations - Sale of Commercial Business (Tables) Sheet http://www.merrimackpharma.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsSaleOfCommercialBusinessTables Discontinued Operations - Sale of Commercial Business (Tables) Tables http://www.merrimackpharma.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsSaleOfCommercialBusiness 17 false false R18.htm 100180 - Disclosure - Fair Value of Financial Instruments (Tables) Sheet http://www.merrimackpharma.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsTables Fair Value of Financial Instruments (Tables) Tables http://www.merrimackpharma.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstruments 18 false false R19.htm 100190 - Disclosure - Accounts Payable, Accrued Expenses and Other (Tables) Sheet http://www.merrimackpharma.com/20240331/taxonomy/role/Role_DisclosureAccountsPayableAccruedExpensesAndOtherTables Accounts Payable, Accrued Expenses and Other (Tables) Tables http://www.merrimackpharma.com/20240331/taxonomy/role/Role_DisclosureAccountsPayableAccruedExpensesAndOther 19 false false R20.htm 100200 - Disclosure - Net Income (Loss) Per Common Share (Tables) Sheet http://www.merrimackpharma.com/20240331/taxonomy/role/DisclosureNetIncomeLossPerCommonShareTables Net Income (Loss) Per Common Share (Tables) Tables http://www.merrimackpharma.com/20240331/taxonomy/role/DisclosureNetIncomeLossPerCommonShare 20 false false R21.htm 100210 - Disclosure - Nature of the Business - Additional Information (Detail) Sheet http://www.merrimackpharma.com/20240331/taxonomy/role/Role_DisclosureNatureOfBusinessAdditionalInformationDetail Nature of the Business - Additional Information (Detail) Details 21 false false R22.htm 100220 - Disclosure - Discontinued Operations - Sale of Commercial Business - Summary of Discontinued Operations (Detail) Sheet http://www.merrimackpharma.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsSaleOfCommercialBusinessSummaryOfDiscontinuedOperationsDetail Discontinued Operations - Sale of Commercial Business - Summary of Discontinued Operations (Detail) Details 22 false false R23.htm 100230 - Disclosure - Discontinued Operations - Sale of Commercial Business - Additional Information (Detail) Sheet http://www.merrimackpharma.com/20240331/taxonomy/role/DisclosureDiscontinuedOperationsSaleOfCommercialBusinessAdditionalInformationDetail Discontinued Operations - Sale of Commercial Business - Additional Information (Detail) Details 23 false false R24.htm 100240 - Disclosure - Fair Value of Financial Instruments - Summary of Assets Measured at Fair Value on a Recurring Basis (Detail) Sheet http://www.merrimackpharma.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfAssetsMeasuredAtFairValueOnRecurringBasisDetail Fair Value of Financial Instruments - Summary of Assets Measured at Fair Value on a Recurring Basis (Detail) Details 24 false false R25.htm 100250 - Disclosure - Fair Value of Financial Instruments - Additional Information (Detail) Sheet http://www.merrimackpharma.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail Fair Value of Financial Instruments - Additional Information (Detail) Details 25 false false R26.htm 100260 - Disclosure - Fair Value of Financial Instruments - Summary of Carrying Values and Fair Values of Financial Instruments (Detail) Sheet http://www.merrimackpharma.com/20240331/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsSummaryOfCarryingValuesAndFairValuesOfFinancialInstrumentsDetail Fair Value of Financial Instruments - Summary of Carrying Values and Fair Values of Financial Instruments (Detail) Details 26 false false R27.htm 100270 - Disclosure - Accounts Payable, Accrued Expenses and Other - Schedule of Accounts Payable, Accrued Expenses and Other (Detail) Sheet http://www.merrimackpharma.com/20240331/taxonomy/role/Role_DisclosureAccountsPayableAccruedExpensesAndOtherScheduleOfAccountsPayableAccruedExpensesAndOtherDetail Accounts Payable, Accrued Expenses and Other - Schedule of Accounts Payable, Accrued Expenses and Other (Detail) Details 27 false false R28.htm 100280 - Disclosure - Stock-Based Compensation - Additional Information (Detail) Sheet http://www.merrimackpharma.com/20240331/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetail Stock-Based Compensation - Additional Information (Detail) Details 28 false false R29.htm 100290 - Disclosure - Net Income (Loss) Per Common Share - Schedule of Outstanding Options Excluded from Computation of Diluted Loss Per Share (Detail) Sheet http://www.merrimackpharma.com/20240331/taxonomy/role/DisclosureNetIncomeLossPerCommonShareScheduleOfOutstandingOptionsExcludedFromComputationOfDilutedLossPerShareDetail Net Income (Loss) Per Common Share - Schedule of Outstanding Options Excluded from Computation of Diluted Loss Per Share (Detail) Details http://www.merrimackpharma.com/20240331/taxonomy/role/DisclosureNetIncomeLossPerCommonShareTables 29 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityRegistrantName - mack-20240331.htm 8 [rq-2601-All-Facts-Filtered] The presentation group ''Subsequent Events - Additional Information (Detail)'' contains us-gaap:StatementClassOfStockAxis, us-gaap:SubsequentEventTypeAxis, which has (have) no default member in the presentation group. Since every fact in the group is defaulted on this (these) axis (axes), all facts have been filtered out. mack-20240331.htm mack-20240331.xsd http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 false false